Biofarm S.A. (BVB:BIO)

Romania flag Romania · Delayed Price · Currency is RON
0.7980
-0.0020 (-0.25%)
At close: Oct 7, 2025
-0.25%
Market Cap786.32M
Revenue (ttm)308.52M
Net Income (ttm)81.22M
Shares Out985.37M
EPS (ttm)0.07
PE Ratio10.66
Forward PEn/a
Dividend0.03 (3.88%)
Ex-Dividend DateAug 18, 2025
Volume19,847
Average Volume43,719
Open0.7960
Previous Close0.8000
Day's Range0.7940 - 0.8060
52-Week Range0.6200 - 0.8980
Beta0.31
RSI34.06
Earnings DateNov 14, 2025

About Biofarm

Biofarm S.A. manufactures and sells medicines in Romania. The company offers a portfolio of products covering therapeutic areas, such as antiallergics, cardiovascular and circulatory, analgesics and antipyretics, dermatology, digestive and metabolic, endocrine, genitourinary, multivitamins, ophthalmology, musculoskeletal, respiratory and ENT, and neurology. It provides prescription and non-prescription medicines, food supplements, medical devices, cosmetics, and other products. The company also exports its products in Azerbaijan, Albania, Georg... [Read more]

Industry Pharmaceutical Preparations
Founded 1921
Employees 373
Stock Exchange Bucharest Stock Exchange
Ticker Symbol BIO
Full Company Profile

Financial Performance

In 2024, Biofarm's revenue was 286.77 million, an increase of 2.31% compared to the previous year's 280.29 million. Earnings were 74.40 million, a decrease of -3.40%.

Financial Statements

News

There is no news available yet.